Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v3-EN
Language French English
Date Updated 2023-04-27 2023-02-09
Drug Identification Number 02163543 02163543
Brand name APO-OXYBUTYNIN APO-OXYBUTYNIN
Common or Proper name OXYBUTYNIN OXYBUTYNIN
Company Name APOTEX INC APOTEX INC
Ingredients OXYBUTYNIN CHLORIDE OXYBUTYNIN CHLORIDE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-31 2023-01-31
Estimated end date 2023-04-28 2023-03-24
Actual end date 2023-04-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments 500 Btt available
Health Canada comments